stromal vascular fraction (SVF)

Recommend reads: FDA SVF warning, big Aspen grant, CSI finale invokes stem cells

SVF

One of the most contentious areas in the regenerative medicine arena is whether a fat tissue product called stromal vascular fraction or SVF is a drug. The FDA says SVF, even in autologous form, is a drug. It is seeking an injunction against a California-based network of SVF clinics but lost the initial case. That […]

Recommend reads: FDA SVF warning, big Aspen grant, CSI finale invokes stem cells Read More »

Can clinic biz US Stem reboot after losing suit? Its email to customers & more

USRM-clinic-email

The unproven stem cell clinic firm US Stem Cell Inc. is in a world of hurt. If a federal judge says you can no longer sell your key commercial offering, how do you survive as a company? US Stem probably has been thinking about that possibility for months. Still, it’s not yet clear where the

Can clinic biz US Stem reboot after losing suit? Its email to customers & more Read More »

In dark augur for clinic industry, court allows class action suit by 100s against Stemgenex

Stemgenex

In the latest blow to the unproven stem cell clinic industry, a California federal district court judge just granted class status to a lawsuit against the fat stem cell clinic Stemgenex. (update: Stemgenex has since filed for bankruptcy). What this means in practical terms is that the lawsuit alleging fraud in marketing by the clinic

In dark augur for clinic industry, court allows class action suit by 100s against Stemgenex Read More »

My take as a biologist on US Stem Cell “natural” claim in federal court case endgame

SVF2

It’s been less than a year since the FDA sued for a permanent injunction against a major stem cell clinic firm in Florida, but there has been much back and forth in court filings in the lawsuit between them and the firm, US Stem Cell. Now the case is with the judge. My prediction remains

My take as a biologist on US Stem Cell “natural” claim in federal court case endgame Read More »

Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network

The Cell Surgical Network is a large and growing group of affiliated stem cell clinics across the US. The Network providers use stromal vascular fraction (SVF) interventions for a host of conditions on a for-profit basis. Drs. Elliot Lander and Mark Berman lead the Network. They agreed to do a Q&A interview with me. Below is Part 1,

Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network Read More »

Stem cell company Intellicell facing new financial wrinkles

Intellicell

It’s difficult to make it as a biotech company, I would say stem cell biotechs in general may have an even rougher time, and one such company,  Intellicell (Intellicell Biosciences, Inc), is showing a number of signs of distress in my opinion. An online financial tool predicts the probability of companies going bankrupt within the next

Stem cell company Intellicell facing new financial wrinkles Read More »

Dr Lookgood, dermatologist to the stars, gets FDA warning letter

Dr-LookGood1

If you ever had a really bad day, March 13, 2012 might have been just such a bad day for one Dr. Steven Victor, aka “Dr LookGood”, because he received an official warning letter from the FDA. Why? Dr. Victor, who reportedly greets each patient with the catch phrase “You look so much more beautiful than your picture”, is

Dr Lookgood, dermatologist to the stars, gets FDA warning letter Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.